Jouko Lauri Saramies

Dr. Jouko Lauri Saramies


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JSJouko Lauri Saramies
Jouko Lauri Saramies
MKMarkku Koiranen
Markku Koiranen
JAJuha Auvinen
Juha Auvinen
HUHannu Uusitalo
Hannu Uusitalo
EHEsko Hussi
Esko Hussi
KSKadri Suija
Kadri Suija
There is a wide variation in the development and course of erectile dysfunction (ED) in men, which confirms the need for prospective studies. We conducted a cross-sectional analysis among the general male population at the baseline (n = 359) and in a follow-up survey (n = 218) 12 years later. The prospective 12-year study included 189 men. ED was assessed using the International Index of Erectile Function questionnaire. The mean age of the participants was 62.0 years at the baseline, while at the 12-year follow-up it was 71.6 years. The crude prevalence of ED was 61.6% at the baseline and 78.9% at the follow-up, and the prevalence tended to increase with age. All of the men aged 75 years or more had at least mild ED. The incidence of ED in every thousand person years was 53.5. A total of 54.5% of the men experienced ED progression, while 39.2% reported no changes in erectile function, and 6.3% experienced ED regression during the 12-year study. The likelihood of ED progression was higher in the older compared with younger age group (odds ratio, OR 5.2 (95% CI: 1.1–26.2)), and the likelihood of ED regression was lower among men with increased depression symptoms (OR 0.3 (95% CI: 0.1–0.6)) and among men with a decreased interest in their sexual life (OR 0.1 (95% CI: 0.0–0.6)). Lifestyle factors such as the consumption of alcohol and smoking were not significantly associated with ED.

1 December 2021 in Primary Care Diabetes
Verified
Journal Article
Closed access
JSJouko Lauri Saramies
Jouko Lauri Saramies
MKMarkku Koiranen
Markku Koiranen
JAJuha Auvinen
Juha Auvinen
HUHannu Uusitalo
Hannu Uusitalo
EHEsko Hussi
Esko Hussi
JTJaakko Tuomilehto
Jaakko Tuomilehto

Verified
Journal Article
Open access
PDF file
ASAnni Saunajoki
Anni Saunajoki
JAJuha Auvinen
Juha Auvinen
ABAini Bloigu
Aini Bloigu
JSJouko Lauri Saramies
Jouko Lauri Saramies
JAAKKO TUOMILEHTOJAAKKO TUOMILEHTO
JAAKKO TUOMILEHTO
MTMarkku Timonen
Markku Timonen
The purpose of this study was to examine and compare the associations between albuminuria and fasting (FPG), 1 h post-load (1 h PG) and 2 h post-load plasma glucose (2 h PG) in an oral glucose tolerance test (OGTT). A total of 496 people free of known diabetes (mean age 72 years) participated in the examinations including the OGTT with plasma glucose measurements at 0, 1, and 2 h and levels of HbA1c. Albuminuria was determined by the urinary albumin-to-creatinine ratio and was defined as ≥3.0 mg/mmol. Compared with those without albuminuria, participants with albuminuria had significantly higher 1 h PG and 2 h PG levels, but not FPG or HbA1c levels. An elevated 1 h PG increased the estimated odds ratio of albuminuria more than three times in people with prediabetic 1 h PG (8.6–11.5 mmol/L: OR 3.60; 95% CI 1.70–7.64) and diabetic 1 h PG (≥11.6 mmol/L: OR 3.05; 95% CI 1.29–7.23). After adjusting for blood pressure and age, the association of elevated 1 h PG with albuminuria remained significant. Prediabetic or diabetic FPG, 2 h PG, or HbA1c did not have a statistically significant association with albuminuria. These findings suggest that 1 h PG seems to be the best glycemic parameter and is useful in recognizing persons with an elevated risk of early kidney disease due to hyperglycemia.

10 October 2024 in Primary Care Diabetes
Verified
Journal Article
Closed access
SBSebastian Becker
Sebastian Becker
KSKadri Suija
Kadri Suija
AVAntti Valpas
Antti Valpas
MKMarkku Koiranen
Markku Koiranen
JAJuha Auvinen
Juha Auvinen
JSJouko Lauri Saramies
Jouko Lauri Saramies

28 January 2025 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
UAUlla Aapola
Ulla Aapola
PMPaula Mosallaei
Paula Mosallaei
JNJanika Nättinen
Janika Nättinen
ISIlona Suurkuukka
Ilona Suurkuukka
JAAKKO TUOMILEHTOJAAKKO TUOMILEHTO
JAAKKO TUOMILEHTO
HUHannu Uusitalo
Hannu Uusitalo
Purpose: To assess the relationship between quality of life (QoL) and ocular surface health within a Finnish population-based cohort. Methods: A cross-sectional study involved 601 individuals born between the years 1933–1956. Ocular surface health and dry eye disease (DED) were clinically evaluated using several diagnostic tests. Participants completed the Ocular Surface Disease Index (OSDI), QoL assessment with the 15D and Medical Outcomes Study 36-Item Short Form Health Survey (SF-36), and the Beck’s Depression Inventory (BDI-II) questionnaires. Various statistical methods were employed to explore the associations between QoL, ocular surface health, and sex disparities. Results: DED had negative impact on QoL in all participants, and especially in women. Adjusted for comorbidities, DED doubled the odds of worse health-related QoL (15D: OR = 2.31 [95% CI: 1.24–4.31, p < 0.01]) and mental health (SF-36 MCS and BDI-II: OR = 2.08 [95% CI: 1.04–4.16, p < 0.05]). Noninvasive tear break-up time (NIBUT) correlated with all QoL scores. In women, the most significant clinical signs correlating with low QoL were NIBUT (15D: r = 0.20, p = 0.002; SF-36 MCS: r = 0.18, p = 0.026), and conjunctival staining (15D: r=-0.19, p = 0.004; BDI-II: r = 0.27, p < 0.001), whereas in men, blepharitis correlated with depression score (BDI-II: r = 0.20, p = 0.036). High OSDI was associated with worse QoL in women, but not in men. Conclusion: This first population-based study assessing general QoL data with objective clinical measures of DED indicated that among elderly population, both symptoms and signs of DED independently impacted different aspects of QoL. In addition, significant sex-differences in these associations were observed and should be considered both in research settings and when assessing and treating people with DED.

6 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CVChrista Ventresca
Christa Ventresca
AVArushi Varshney
Arushi Varshney
POPeter Orchard
Peter Orchard
HVHa T H Vu
Ha T H Vu
YTYao-Chang Tsan
Yao-Chang Tsan
SPSteve Parker
Steve Parker
Summary: Fibro-adipogenic progenitors (FAPs) in skeletal muscle have been implicated in type 2 diabetes (T2D), yet their heterogeneity and context-dependent regulation remain poorly understood. Here, we establish induced pluripotent stem cell (iPSC)-derived FAPs as a model of primary FAPs by leveraging a unique resource: iPSC lines and skeletal muscle biopsies obtained from 34 individuals, a subset of 30 profiled using single-nucleus multiomics. Donor-matched comparisons reveal iPSC-FAPs recapitulate the transcriptome, epigenome, and subtype composition of primary FAPs. Using single-nucleus multiomics, we show that high-insulin exposure drives iPSC-FAPs toward an adipogenic fate - and this adipogenic subtype is enriched for T2D GWAS signals, an enrichment undetectable at baseline. We map the T2D-associated rs3814707 non-coding signal to LTBP3 , a gene that influences FAP adipogenic differentiation. These findings reveal how disease-relevant regulatory mechanisms can be masked in unstimulated cells and establish iPSC-FAPs as a powerful platform for dissecting the state-dependent biology of complex metabolic disease.